Homocysteine, folic acid, and the prevention of vascular disease.
Reduction of circulating homocysteine levels by folic acid suggests an additional approach to the prophylaxis of certain forms of vascular disease related to atherogenic amino acids.
D001157:Arterial Occlusive Diseases / Q000378:metabolism / Q000517:prevention & control; D001161:Arteriosclerosis / Q000378:metabolism / Q000517:prevention & control*; D005492:Folic Acid / Q000008:administration & dosage* / Q000378:metabolism; D005494:Folic Acid Deficiency / Q000188:drug therapy*; D006710:Homocysteine / Q000378:metabolism*; D006801:Humans; D008661:Metabolism, Inborn Errors; D014652:Vascular Diseases / Q000378:metabolism / Q000517:prevention & control*; D014805:Vitamin B 12 / Q000378:metabolism; D014806:Vitamin B 12 Deficiency / Q000378:metabolism*
D006710:Homocysteine; D005492:Folic Acid; D014805:Vitamin B 12